SE0000872095
SE0000872095
Swedish Orphan Biovitrum AB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 28.238.000.000 | 26.027.000.000 | 8.5% |
| Cost of Revenue | 6.252.000.000 | 5.785.000.000 | 8.1% |
| Gross Profit | 21.986.000.000 | 20.242.000.000 | 8.6% |
| 21.064.000.000 | 14.625.000.000 | 44.0% | |
| Operating Income | 922.000.000 | 5.617.000.000 | 83.6% |
| Pretax Income | 34.000.000 | 4.407.000.000 | 99.2% |
| Net Income Common Stockholders | 478.000.000 | 3.885.000.000 | 87.7% |
| -- | -- | -- | |
| -- | -- | -- |